Skip to main content
RecallFDAfda-F-1189-2019UNDECLARED ALLERGEN

Hikari Enjuku Koji Miso Mutenka; 26.6 oz. plastic tub with lid. UPC 4 905663 003007

Category
Units Affected
224
Recall Date
February 1, 2019
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1189-2019.

Miso product manufactured in Japan was distributed in US with no English labeling and therefore soy beans not properly declared on label as an allergen.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1189-2019.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Hikari Miso International, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1189-2019.

Hikari Miso International, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Hikari Miso International, Inc. Recall FAQ

Hikari Miso International, Inc. is the subject of a food safety report: Hikari Enjuku Koji Miso Mutenka; 26.6 oz. plastic tub with lid. UPC 4 905663 003007. The notice was published on February 1, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 224 units are potentially affected.